Evolution of the Global Burden of Viral Infections from Unsafe Medical Injections, 2000–2010

Abstract

BackgroundIn 2000, the World Health Organization estimated that, in developing and transitional countries, unsafe injections accounted for respectively 5%, 32% and 40% of new infections with HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Safe injection campaigns were organized worldwide. The present study sought to measure the progress in reducing the transmission of these viruses through unsafe injections over the subsequent decade.MethodsA mass action model was updated, to recalculate the number of injection-related HIV, HCV and HBV infections acquired in 2000 and provide estimates for 2010. Data about the annual number of unsafe injections were updated. HIV prevalence in various regions in 2000 and 2010 were calculated from UNAIDS data. The ratio of HIV prevalence in healthcare settings compared to the general population was estimated from a literature review. Improved regional estimates of the prevalence of HCV seropositivity, HBsAg and HBeAg antigenemia were used for 2000 and 2010. For HIV and HCV, revised estimates of the probability of transmission per episode of unsafe injection were used, with low and high values allowing sensitivity analyses.ResultsDespite a 13% population growth, there was a reduction of respectively 87% and 83% in the absolute numbers of HIV and HCV infections transmitted through injections. For HBV, the reduction was more marked (91%) due to the additional impact of vaccination. While injections-related cases had accounted for 4.6%–9.1% of newly acquired HIV infections in 2000, this proportion decreased to 0.7%–1.3% in 2010, when unsafe injections caused between 16,939 and 33,877 HIV infections, between 157,592 and 315,120 HCV infections, and 1,679,745 HBV infections.ConclusionFrom 2000 to 2010, substantial progress was made in reducing the burden of HIV, HCV and HBV infections transmitted through injections. In some regions, their elimination might become a reasonable public health goal.

Recommendations on hepatitis C screening for adults

“…Unlike the nonimmigrant population, these persons are at increased risk for HCV because of iatrogenic exposure in their country of origin (e.g., lack of standard precautions, or as a result of medical or dental procedures with contaminated equipment) and not necessarily from injection drug use or other higher-risk behaviours. 83 The CFPC/PHAC guidance 14 recommends testing for HCV in individuals who were "born, traveled or resided in a region in which HCV infection is more common." A list of endemic countries and a related map are provided in Appendix 6 (available at www.…”

A Study on Bacterial Contamination of Multidose Vaccine Vials in Southeast of Iran

“…Unsafe injection practices are associated with more than 1.3 million deaths, and the cost of unsafe injections are estimated at approximately 535 million dollars per year (6). During 2000 -2010, the absolute number of HIV and HCV infections, transmitted through unsafe injection practices, has shown a reduction of 87% and 83%, respectively (7). However, in some developing countries, unsafe injections are commonplace and still pose a major public health challenge.…”

Breaking out of silos – the need for critical paradigm reflection in HIV prevention

“…For example, the epidemiological estimates that inform Tanzanian prevention policies (Sando et al 2014) attribute 2.1% to recreational injection drug use, and 0.0% to iatrogenic transmission (with all remaining infections attributed to sexual transmission). Admittedly, donors such as PEPFAR have invested heavily in blood safety in several African countries over the last decade, and the situation does appear to have improved recently (Pépin et al 2014). Nevertheless, in a country with well-documented routine failures in infection control and in which 30% of health facilities (and 15% of hospitals) still have no capacity to diagnose HIV (MOHSW 2013, 13), claims of zero iatrogenic transmissions should require strong justification.…”